Citadel Advisors

Citadel Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Citadel Advisors’s Portfolio SPRY Stock Details SPRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$118K	Sell	14,700 -54,900	-79%	-$526K	﹤0.01%	11868
2025 Q4	$811K	Sell	69,600 -58,700	-46%	-$571K	﹤0.01%	7886
2025 Q3	$1.29M	Buy	128,300 +29,600	+30%	+$425K	﹤0.01%	6989
2025 Q2	$1.72M	Sell	98,700 -43,900	-31%	-$633K	﹤0.01%	5989
2025 Q1	$1.79M	Sell	142,600 -87,900	-38%	-$1.06M	﹤0.01%	5739
2024 Q4	$2.43M	Buy	230,500 +69,300	+43%	+$971K	﹤0.01%	5228
2024 Q3	$2.34M	Buy	161,200 +111,000	+221%	+$1.32M	﹤0.01%	5240
2024 Q2	$427K	Buy	50,200 +8,200	+20%	+$72.8K	﹤0.01%	8381
2024 Q1	$429K	Sell	42,000 -12,700	-23%	-$94.7K	﹤0.01%	8717
2023 Q4	$300K	Sell	54,700 -60,900	-53%	-$267K	﹤0.01%	9154
2023 Q3	$437K	Buy	115,600 +92,400	+398%	+$607K	﹤0.01%	8364
2023 Q2	$155K	Buy	23,200 +21,000	+955%	+$140K	﹤0.01%	10288
2023 Q1	$14.3K	Buy	+2,200	New	+$16.9K	﹤0.01%	13319
2022 Q3	–	Sell	-88,000	Closed	-$373K	–	13555
2022 Q2	$373K	Buy	+88,000	New	+$307K	﹤0.01%	9302

Other funds holding SPRY

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return